Elon Musk‘s brain implant company Neuralink has tapped a top U.S. health regulator responsible for overseeing the company and its competitors, according to a company announcement. U.S. FDA executive David McMullen will lead Neuralink’s medical affairs division, according to the company’s website, a prominent appointment that calls into question the Trump administration’s promise to end the revolving door of government regulators moving into the private sector.
McMullen most recently served as director at the Food and Drug Administration’s Office of…
